Genuity Science Investor
Some of the world's most advanced clinico-omic data and insights to enable better disease discovery to improve human health.
Headquarters:
Boston, Massachusetts, United States
Last Funding Type:
Series C
Investors Number:
8.0
Last Funding Date:
2018-11-27
Acquisitions Number:
Made Acquisitions, Was Acquired
Employee Number:
101-250
Total Funding:
455000000.0
Founded Date:
2013-01-01
Technology:
Cancer
Estimated Revenue:
$10M to $50M
Zip:
NA
Industry:
End-to-End Drug Development
Funding Status:
M&A